Epigenetic heterogeneity underlies the diversity of cell states found in health and disease. A new study presents a method for profiling of histone modifications in single cells and applies it to identify rare chromatin states, possibly predisposed to drug resistance, within patient-derived tumor xenografts.
References
Rathert, P. et al. Nature 525, 543–547 (2015).
Kim, C. et al. Cell 173, 879–893.e13 (2018).
Hwang, B., Lee, J. H. & Bang, D. Exp. Mol. Med. 50, 96 (2018).
Cusanovich, D. A. et al. Science 348, 910–914 (2015).
Buenrostro, J. D. et al. Nature 523, 486–490 (2015).
Cusanovich, D. A. et al. Cell 174, 1309–1324.e18 (2018).
Grosselin, K. et al. Nat. Genet. https://doi.org/10.1038/s41588-019-0424-9 (2019).
Rotem, A. et al. Nat. Biotechnol. 33, 1165–1172 (2015).
Zhang, X. et al. Mol. Cell 73, 130–142.e5 (2019).
Cao, J. et al. Nature 566, 496–502 (2019).
Clark, S. J. et al. Nat. Commun. 9, 781 (2018).
Cao, J. et al. Science 361, 1380–1385 (2018).
Hainer, S. J., Bošković, A., McCannell, K. N., Rando, O. J. & Fazzio, T. G. Cell https://doi.org/10.1016/j.cell.2019.03.014 (2019).
Merino, D. et al. Nat. Commun. 10, 766 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Minkina, A., Shendure, J. Expanding the single-cell genomics toolkit. Nat Genet 51, 931–932 (2019). https://doi.org/10.1038/s41588-019-0429-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-019-0429-4
- Springer Nature America, Inc.